Ikonisys SA announced that the publication of its 2023 annual financial report will be made by May, 27 and not on April, 30. The Company experienced a technical delay in the finalization of its audited consolidated financial statements, due to the internal reorganization following the integration of Hospitex.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 EUR | 0.00% |
|
-3.45% | -10.26% |
Jun. 13 | Ulisse Biomed and Ikonisys together to innovate oncology diagnostics | AN |
Jun. 12 | Ikonisys, Ulisse Biomed to Collaborate on New Cancer Diagnostic Technologies | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.26% | 15.87M | |
-10.93% | 11.41B | |
-11.84% | 7.53B | |
+31.42% | 5.62B | |
+4.38% | 5.54B | |
-17.33% | 3.82B | |
+7.01% | 2.6B | |
-64.33% | 2.37B | |
-10.17% | 2.26B | |
+24.35% | 2.16B |
- Stock Market
- Equities
- ALIKO Stock
- News Ikonisys S.A.
- Ikonisys Announces the Postponement of the Publication of Its Annual Financial Report